ArticlePEC innovation2026
Community-informed design of personalized patient-facing materials to facilitate ED-initiated treatment of opioid use disorder.
Article in PEC innovation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Objectives: Despite evidence for safe and effective treatment of Opioid Use Disorder (OUD) with medications (MOUD), few patients engage in treatment. Among other barriers, patients report challenges related to generic ED discharge materials that fail to meet individual patients' MOUD-related needs and preferences. Our study aimed to design and develop an intervention to address this gap. Methods: This study adopted a community-engaged, user-centered design approach. A community advisory board (CAB), comprising individuals with lived experience of OUD, ED physicians, addiction experts, and community program staff, informed intervention design. An initial prototype was designed to address CAB-identified challenges The prototype was iteratively refined with end-user feedback to develop the final product. Results: The CAB-identified challenges to MOUD engagement included lengthy, generic MOUD discharge materials that fail to meet the urgent needs of patients in opioid withdrawal. The initial prototype was refined with feedback from 20 individuals with OUD and ED clinicians to develop the final product. The final product included a novel, multi-component intervention consisting of: (1) A clinician-facing intake form to identify patients' MOUD preferences and socio-economic needs, (2) a paper-based, customized ED discharge summary, containing essential information tailored to individual needs, (3) a QR code accessible, digital component, containing supplemental information, and (4) a patient-facing poster for the ED care area to encourage patients to discuss MOUD treatment with their clinicians. Innovation/conclusion: This innovative intervention can deliver customized MOUD-related patient education materials at ED discharge. A future trial will evaluate the intervention's effectiveness in improving patient MOUD engagement.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.